Airworthiness Directives; The Boeing Company Airplanes
The FAA proposes to supersede Airworthiness Directive 2024-01-01 for certain The Boeing Company Model 787-8, 787-9, and 787-10 airplanes to address an unsafe condition.
BUSINESS NEWS
Find articles by title or summary.
The FAA proposes to supersede Airworthiness Directive 2024-01-01 for certain The Boeing Company Model 787-8, 787-9, and 787-10 airplanes to address an unsafe condition.
The US Environmental Protection Agency (EPA) has established an exemption for residues of Vadescana double-stranded RNA in honey and honeycomb when used according to the label and good agricultural practices, eliminating the need for a maximum permissible level.
The Environmental Protection Agency (EPA) is correcting a cancellation order for chlorpyrifos, specifically rescinding the termination of asparagus use in Michigan for Pilot 4E Chlorpyrifos Agricultural Insecticide.
The U.S. Nuclear Regulatory Commission (NRC) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review, related to the Visitor Access Request System (VARS).
The 727th Meeting of the Advisory Committee on Reactor Safeguards (ACRS) took place, focusing on reactor safety issues. The committee, established by the U.S. Nuclear Regulatory Commission, aims to provide recommendations for improving reactor safety.
Informal Working Groups 1-4 of the WRC-27 Advisory Committee have scheduled public meetings for the 2027 World Radiocommunication Conference. The meetings' dates and times have not been specified.
The Federal Communications Commission (FCC) published a correction to its May 30, 2025, document regarding Petitions for Reconsideration, correcting an incorrect date for filing replies to oppositions.
The Federal Communications Commission proposes requiring providers to implement non-IP caller ID authentication frameworks, aligning with the TRACED Act requirements.
The Federal Communications Commission is seeking public comment on revising the fee schedule for FY 2025 and addressing several additional regulatory fee issues.
The Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement for termination settlement proposal forms (SF 1435-1440) under the Paperwork Reduction Act.
The Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of an approved information collection requirement related to indirect cost rate proposals, payments to small business subcontractors, and bankruptcy notifications under the Paperwork Reduction Act.
The Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement regarding Federal Acquisition Regulation part 46 requirements, as mandated by the Paperwork Reduction Act.
The Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement regarding Federal Acquisition Regulation part 7 requirements, as mandated by the Paperwork Reduction Act.
The Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement regarding cost accounting standards administration, as mandated by the Paperwork Reduction Act.
The USTR is seeking public comments on the Caribbean Basin Initiative's performance and eligibility for benefits by December 31, 2025, to inform its report to Congress.
The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to discuss the biologic license application for Belantamab Mafodotin, and is seeking public comments on the matter.
The FDA has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, as required by the Paperwork Reduction Act of 1995.
The FDA is seeking public comment on its proposed collection of information related to medical device accessory classification requests, as required by the Paperwork Reduction Act of 1995.
The FDA is seeking public comment on proposed reporting requirements for firms exporting unapproved medical devices, as mandated by the Paperwork Reduction Act of 1995.
The Food and Drug Administration is seeking public comment on its proposed collection of information related to its Manufactured Food Regulatory Program Standards under the Paperwork Reduction Act of 1995.
The FDA has announced the availability of a final guidance for industry on pre-submission facility correspondence related to prioritized generic drug submissions, which outlines the facility information to be submitted and how the FDA will use it to set review goals for priority ANDAs.
The FDA is hosting a public meeting to gather public input on the use of unapproved prescription drugs containing fluoride in children, and is establishing a public docket for comments on the topic.
The US Food and Drug Administration (FDA) has determined the regulatory review period for BRIUMVI, a human biological product, following patent extension applications submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for POMBILITI, a human biological product, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of IMPELLA RP FLEX WITH SMART ASSIST, a medical device, following submissions to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has determined the regulatory review period for the AVEIR VR Leadless System, a medical device, following patent extension applications submitted to the US Patent and Trademark Office (USPTO).
The FDA has determined the regulatory review period for XOLREMDI, a human drug product, following submissions to the USPTO for patent extension, as required by law.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for VOYDEYA, a human drug product, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for VAFSEO, a patent extension application submitted to the US Patent and Trademark Office (USPTO) for a human drug product patent.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for patent extension of the NAVITOR TRANSCATHETER AORTIC VALVE IMPLANT, following submissions to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has determined the regulatory review period for ZEVTERA, a human drug product, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for VOWST, a human biological product, in response to patent extension applications submitted to the US Patent and Trademark Office (USPTO).
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for RIVFLOZA, a human drug product, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).
The FDA has published a notice determining the regulatory review period for ROLVEDON, a human biological product, following a patent extension application submitted to the USPTO.
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the extension of a patent for a human biological product, submitted by the US Patent and Trademark Office (USPTO).
The Federal Housing Finance Agency (FHFA) is proposing to rescind a System of Records Notice (SORN) related to its Applicant Tracking System (FHFA-25), which was decommissioned and no longer maintained by the Agency.
A US Federal court has overturned the Animal and Plant Health Inspection Service's (APHIS) May 2020 final rule on genetically modified organisms, restoring the pre-May 2020 regulations and requiring APHIS to revise its regulations to conform to the court's decision, effective December 2, 2024.
The US government is seeking public feedback on a proposed revision to the Supplemental Nutrition Assistance Program (SNAP), which requires states to report lottery and gambling winnings and establish agreements with gaming entities to identify ineligible participants.
The Department of Commerce is seeking public input on its proposed and ongoing information collections, including the Annual Survey of U.S. Direct Investment Abroad, as part of its effort to reduce the burden on the public and assess the impact of its data collection requirements.
The US Department of Commerce is currently accepting applications for 7 membership positions on the 22-member American Fisheries Advisory Committee, with selected individuals serving a three-year term
The U.S. Navy has been granted permission to harm marine mammals as part of its repair and replacement project at Naval Station Norfolk in Norfolk, Virginia, in accordance with the Marine Mammal Protection Act.
The U.S. government is requesting public input on a proposed survey to gather socioeconomics data on coral reef conservation in South Florida, with the goal of informing the 2026 survey
The U.S. Department of Commerce has concluded that certain Spanish producers/exporters sold olive products at below-market prices during the review period, August 1, 2022, through July 31, 2023.
The U.S. Department of Commerce has determined that CS Wind Malaysia Sdn Bhd, a leading manufacturer of utility scale wind towers, received countervailable subsidies from January 1, 2022, through December 31, 2022, prompting a partial rescission of the administrative review.
The U.S. Department of Commerce has released the final results of its 2022-2023 review of the antidumping duty order on stainless steel flanges imported from India, correcting a spelling error in a company name
The U.S. Department of Commerce has determined that Shanghai Yueda Nails Co., Ltd. sold steel nails from China in the U.S. at prices below normal value during the review period, resulting in a final rescission of review for part of the subject merchandise.
The U.S. Department of Commerce and the U.S. International Trade Commission have determined that revoking the antidumping duty order on malleable cast iron pipe fittings from China would likely lead to continued dumping and material injury to the U.S. industry, so the order will continue.
The University of Washington, along with other institutions, has submitted an application to the US government for duty-free entry of scientific instruments, aiming to facilitate international collaborations and research in the field of science
The U.S. Department of Commerce has found that Chinese exporters sold wood mouldings and millwork products at below-market prices during a recent review period, and is rescinding the review for 20 of the companies involved, leaving 18 companies subject to antidumping duties.
The U.S. Department of Commerce has concluded that Mexican light-walled rectangular pipe and tube was sold in the U.S. at a price lower than its normal value during the review period, August 1, 2022, through July 31, 2023.